相关实验视频
Updated: Jun 20, 2025
11:53
Cecal Ligation Puncture Procedure
Published on: May 7, 2011
54.8K
在中度性败血症诱导的凝血病患者中未分离的肝素的疗效:一项观察性研究
Noritaka Ushio1, Kazuma Yamakawa1, Katsunori Mochizuki1
1Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Thrombosis research
|July 18, 2024
概括
在败血症患者中,早期服用未分离的肝素与减少住院死亡率有关,特别是在中度败血症引起的凝血病患者中. 这种治疗没有显著增加出血或血栓栓塞的风险.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的指导方针推低分子量肝素用于血栓塞发症的VTE预防.
- 观察数据表明抗凝剂可能有利于患有凝血病的败血症患者.
- 在败血症中未分离的肝素的最佳标仍然不清楚.
研究的目的:
- 为了调查哪些败血症患者最能从未分离的肝素中受益.
- 评估早期未分离的肝素给药与败血症的结果之间的关联.
- 为了确定特定的亚组的败血症患者体验的生存益处从肝素.
主要方法:
- 在日本从2006-2019年对30,342名成年败血症患者进行了回顾性观察性研究.
- 医院住院死亡率,出血和血栓塞栓事件的比较,在接受早期 (在72小时内) 肝素治疗的患者和未接受治疗的患者之间.
- 多变量逻辑回归和小组分析,根据患者和治疗变量进行调整.
主要成果:
- 早期服用肝素与降低住院死亡率有关 (aOR:0.735).
- 没有发现肝素与大出血或血栓栓塞的风险增加之间有显著的关联.
- 在患有中度凝血病的败血症患者和败血症诱导的凝血病得分为3或4的败血症患者中观察到显著的生存益处.
结论:
- 在败血症中早期未分离的肝素给药与较低的住院死亡率有关.
- 生存益处在中度败血症诱导的凝血病患者中最为明显.
- 肝素的使用并没有显著增加重大出血或血栓栓塞并发症的风险.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
668
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
668
01:09Coagulation
6.0K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.0K
01:05Introduction to Hemostasis
7.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
7.1K